Literature DB >> 5448779

Failure of a pure progestogen contraceptive to affect serum levels of iron, transferrin, protein-bound iodine, and transaminase.

L W Powell, J M Jacobi, T J Gaffney, R Adam.   

Abstract

Medroxyprogesterone acetate, a pure progestational agent which is not metabolized to oestrogen, was given to 30 women and shown to have no effect on the serum levels of iron, total iron-binding capacity, transferrin, and protein-bound iodine. Eighteen of these women had previously taken oral contraceptives of the combined oestrogen-progestogen "sequential" type, and during that time these serum levels were raised. Nevertheless, the levels all fell significantly after medroxyprogesterone acetate was given and the "sequential" oral contraceptive was stopped. In a further 12 postpartum women the serum levels did not change significantly after medroxyprogesterone acetate.These observations strongly suggest that raised plasma protein levels resulting from the administration of oral contraceptives are due to the oestrogen component.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5448779      PMCID: PMC1701160          DOI: 10.1136/bmj.3.5716.194

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  EFFECT OF AN OVULATORY SUPPRESSANT ON THE SERUM PROTEIN-BOUND IODINE AND THE RED-CELL UPTAKE OF RADIOACTIVE TRI-IODOTHYRONINE.

Authors:  C S HOLLANDER; A M GARCIA; S H STURGIS; H A SELENKOW
Journal:  N Engl J Med       Date:  1963-09-05       Impact factor: 91.245

2.  Oral contraceptives and thyroid function tests.

Authors:  D Winikoff; K Taylor
Journal:  Med J Aust       Date:  1966-07-16       Impact factor: 7.738

3.  Effect of oral contraceptives on haemoglobin, packed-cell volume, serum-iron, and total iron-binding capacity in healthy women.

Authors:  J L Burton
Journal:  Lancet       Date:  1967-05-06       Impact factor: 79.321

4.  Investigations on the effect of an oral contraceptive and its components on liver function, serum proteins, copper, coeruloplasmin and gamma-glutamyl peptidase in postmenopausal women.

Authors:  H Adlercreutz; A Eisalo; A Heino; T Luukkainen; I Penttilä; H Saukkonen
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

5.  Oral contraceptives and blood-iron.

Authors:  M Briggs; M Staniford
Journal:  Lancet       Date:  1969-10-04       Impact factor: 79.321

6.  Effect of combined oestrogen-progestogen oral contraceptives on serum-levels of alpha 2-macroglobulin, transferrin, albumin, and IgG.

Authors:  C H Horne; R J Weir; P W Howie; R B Goudie
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

7.  Serum enzyme activity and bromsulphalein retention during use of oral contraceptives.

Authors:  L Wilbert; E Severidt; L Kallmann; T Hillmer; W Creutzfeldt
Journal:  Ger Med Mon       Date:  1969-09

8.  Immunochemical quantitation of human transferrin in pregnancy and during the administration of oral contraceptives.

Authors:  J M Jacobi; L W Powell; T J Gaffney
Journal:  Br J Haematol       Date:  1969-11       Impact factor: 6.998

  8 in total
  3 in total

1.  Sex-related differences in hematological values. A study on the erythrocyte and granulocyte count, plasma iron and iron-binding proteins in human transsexuals on contrasexual hormone therapy.

Authors:  A Rosenmund; H P Köchli; M P König
Journal:  Blut       Date:  1988-01

Review 2.  [Metabolic studies under administration of oral contraceptives. A review].

Authors:  S Hauschildt
Journal:  Z Ernahrungswiss       Date:  1978-03

Review 3.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.